Ultrasound findings of the optic nerve and its arterial venous system in multiple sclerosis patients with and without optic neuritis vs. healthy controls  by Carraro, Nicola et al.
Perspectives in Medicine (2012) 1, 381—384
Bartels E, Bartels S, Poppert H (Editors):
New Trends in Neurosonology and Cerebral Hemodynamics — an Update.
Perspectives in Medicine (2012) 1, 381—384
j ou rna l homepage : www.e l sev i e r . com/ loca te/pe rmed
Ultrasound ﬁndings of the optic nerve and its arterial
venous system in multiple sclerosis patients with and
without optic neuritis vs. healthy controls
Nicola Carraroa,∗, Giovanna Servilloa, Vittoria M. Sarraa,
Angelo Bignaminib, Gilberto Pizzolatoa, Marino Zorzona
a Department of Medical Sciences, University of Trieste, Italy
b School of Specialization in Hospital Pharmacy, University of Milan, Italy
KEYWORDS
Optic Neuritis;
Ophthalmic venous
ﬂow;
Optic Nerve atrophy;
Doppler ultrasound
imaging
Summary
Background: Optic Neuritis (ONe) is common in Multiple Sclerosis (MS). The aim of this study
was to evaluate the Optic Nerve (ONr) and its vascularisation in MS patients with and without
previous ONe and in Healthy Controls (HC).
Methods: We performed high-resolution echo-color ultrasound examination in 50 subjects (29
MS patients and 21 HC). By a suprabulbar approach we measured the ONr diameter at 3mm from
the retinal plane and at another unﬁxed point. We assessed the ﬂow velocities of Ophthalmic
Artery (OA), Central Retinal Artery (CRA) and Central Retinal Vein (CRV) measuring the Peak
Systolic Velocity (PSV) and the End Diastolic Velocity (EDV) for the arteries and the Maximal
Velocity (MaxV), Minimal Velocity (MinV) and mean Velocity (mV) for the veins. The Pulsatility
Index (PI) and the Resistive Index (RI) were also calculated.
Results: No signiﬁcant variation for OA supply was found as well as no signiﬁcant variation for
CRA supply, while signiﬁcant higher PI in the CRV of non-ONe MS eyes vs. both HC and ONe
MS eyes was measured. We found that ONr diameter was decreased signiﬁcantly from HC to
non-ONe MS eyes and ONe MS eyes.
Conclusions: Ultrasound examination of ONr and its vascularisation is feasible and can demon-
strate ON atrophy. The increase of CRV PI in unaffected eyes of MS patients is intriguing and
seems not associated to ONr atrophy. Larger studies are needed to conﬁrm these results.
© 2012 Elsevier GmbH.
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ptic Neuritis (ONe) is a common feature of Multiple Sclero-
is (MS) both in the early phase and during the disease course
1].
MS and ONe are due to demyelination [2], but it has been
ostulated that vascular mechanisms may have a role in MS
nd ONe pathogenesis [3—6].
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Figure 1 Sagittal B-mode ultrasound scan of a right eye: Optic
Nerve (asterisk) with its meningeal sheath (arrow).
Figure 2 Sagittal B-mode ultrasound scan of a left eye:
measure of the Optic Nerve diameter, with and without the
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According to a recent hypothesis, cerebrospinal venous
ystem alterations may contribute to the development of
he disease and may drive its clinical course [7,8]. As a mat-
er of fact, a correlation between the hemodynamic pattern
f Chronic Cerebrospinal Venous Insufﬁciency (CCSVI) and
he clinical features in patients with MS has been described
9]. In particular, ONe at onset seems to be associated
ith Internal Jugular Veins (IJV) and/or of proximal Azy-
ous Vein (AV) high grade stenosis, with consequent reﬂux in
he deep cerebral veins. The blood then ﬂows to the ptery-
oid plexus, and from there to the facial veins via the deep
acial vein, to the cavernous sinus and to the ophthalmic
eins.
While changes in the hemodynamics of the eye’s arterial
ystem, detected by Doppler ultrasound sonography, have
een previously described in MS patients with both acute and
hronic ONe [10—13], the venous ﬂow has not been studied
et, as far as we know.
Taking into account the peculiar environment of the
rterial-venous system supplying and draining the Optic
erve, we have considered it as a representative site
or studying the relationship between veins and nervous
arenchyma. For this purpose we investigated if any blood
ow alteration, possibly contributing to MS disease process,
ould be recorded.
Aim of the study was to evaluate the vascularisation of
he Optic Nerve (ONr) by means of color Doppler ultra-
onography in MS patients with and without previous ONe.
urthermore, the possibility to measure the ONr thickness
y ultrasound sonography was assessed. We compared Optic
erve anatomical and vascular features of MS patients with
hose of age- and gender-matched Healthy Controls (HC).
ethods
ith a high-resolution echo-color duplex ultrasound equip-
ent we studied the ONr and its vascularisation [i.e.
phthalmic Artery (OA), Central Retinal Artery (CRA), Cen-
ral Retinal Vein (CRV)] in 29 Relapsing—Remitting (RR)
linically deﬁnite MS patients [14] and 21 age- and gender-
atched HC, volunteers. Table 1 shows the characteristics
f the subjects studied. Seventeen MS patients have had an
Ne at least one year before examination (5 have had a
ight ONe, 7 a left ONe and ﬁve a bilateral ONe) while 12 MS
atients have not suffered from ONe. All MS patients under-
ent a Visual Evoked Potentials Examination to conﬁrm the
Ne diagnosis.
By means of a Toshiba Aplio XG, equipped with a lin-
ar probe (PLT-1204AX: 7.2-14MHz), we insonated the ONe
n
t
d
t
Table 1 Charateristics of study subjects.
Variable Controls (N = 21)
Sex
Females, n (%) 15 (71.4%)
Males, n (%) 6 (28.6%)
Age
Mean± SD 34.0± 7.5
Median [RIQ] 31 [29—38]
a Chi-square test.
b Independent samples t-test.eningeal sheath, in an unﬁxed site where the maximum nerve
iameter is detectable.
Fig. 1) and measured the diameter of ONr, with and with-
ut the meningeal sheaths, at two distances, the ﬁrst at
mm from the retinal plane (Fig. S1, online supplemen-
ary ﬁle) and the second at an unﬁxed point where the
erve structures were best recognised (maximum diame-
er), through the usual suprabulbar approach (Fig. 2). We
etected the OA (Fig. 3) and CRA (Fig. S2, online supplemen-
ary ﬁle) ﬂow velocities [Peak Systolic Velocity (PSV), End
MS (N = 29) Total (N = 50) p
26 (89.7%) 41 (82.0%)
0.098a
3 (10.3%) 9 (18.0%)
34.8± 7.5 34.4± 7.4
0.697b36 [28—40] 35 [29—40]
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Figure 3 Color Doppler and velocity waveforms of a right
Ophthalmic Artery. Measurement of the PSV (indicated as
Figure 4 Color Doppler and velocity waveforms of right Cen-
tral Retinal Vein. Measurement of the MV (indicated as Vmax),
M
vVmax), EDV (indicated as Ved), mV (indicated as Vm p: mean of
peak velocities) and Vm m (mean of mean velocities), PI and RI.
Diastolic Velocity (EDV), mean Velocity (mV)], and the CRV
ﬂow velocities [(Maximum Velocity (MV), Minimum Velocity
(MinV), mean Velocity (mV)] and calculated, for each blood
vessel, the Pulsatility Index (PI) and the Resistive Index (RI)
(Fig. 4).
3
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Table 2 Arterial and Venous ﬂow variables of the Optic Nerve Vas
without previous Optic Neuritis and Healthy Controls.
Variable Controls (N = 42) MS, not affected
eyes (N = 36)
OA
PSV 48.20 ± 12.93 48.71 ± 12.81
EDV 12.84 ± 4.22 12.58 ± 3.56
mV 23.01 ± 7.37 23.16 ± 6.02
RI 0.73 ± 0.05 0.74 ± 0.06
PI 1.58 ± 0.28 1.59 ± 0.37
CRA
PSV 14.37 ± 3.71 16.20 ± 5.75
EDV 4.60 ± 1.78 4.97 ± 2.54
mV 7.88 ± 2.48 8.95 ± 3.73
RI 0.70 ± 0.14 0.70 ± 0.09
PI 1.29 ± 0.42 1.32 ± 0.39
CRV
MV 8.20 ± 2.74 9.01 ± 3.60
MinV 5.76 ± 2.03 5.99 ± 2.28
mV 6.80 ± 2.22 7.34 ± 2.63
RI 0.30 ± 0.09 0.36 ± 0.14
PI 0.26 ± 0.08 0.29 ± 0.09
ONr 3mm 2.95 ± 0.44 2.86 ± 0.42
ONr + sheath 3mm 5.19 ± 0.84 5.09 ± 0.65
MONr 3.38 ± 0.45 3.11 ± 0.37
ONr + sheath 5.92 ± 0.70 5.58 ± 0.63
OA, Ophthalmic Artery; CRA, Central Retinal Artery; CRV, Central Retin
Peak Systolic Velocity; EDV, End Diastolic Velocity; mV, mean Velocity; M
PI, Pulsatility Index.
a 2-Sided Dunnett t-test vs. controls, MS not affected eyes.
b 2-Sided Dunnett t-test vs. controls, MS affected eyes.inV (indicated as Vmin), mV (indicated as Vm p: mean of peak
elocities) and Vm m (mean of mean velocities), PI and RI.
Overall, we examined and compared 42 eyes of HC with
6 unaffected and 22 affected eyes of RR MS patients.
The study was approved by the local Ethics Committee.
ritten informed consent was obtained from all patients and
C.
cularization, measured in Multiple Sclerosis Patients with and
MS, affected
eyes (N = 22)
p ANOVA pa pb
42.03 ± 13.83 ns ns ns
11.64 ± 6.54 ns ns ns
20.76 ± 9.59 ns ns ns
0.73 ± 0.09 ns ns ns
1.60 ± 0.54 ns ns ns
13.64 ± 4.80 ns ns ns
4.19 ± 2.33 ns ns ns
7.47 ± 3.22 ns ns ns
0.70 ± 0.12 ns ns ns
1.37 ± 0.48 ns ns ns
7.73 ± 4.37 ns ns ns
5.42 ± 2.83 ns ns ns
6.41 ± 3.30 ns ns ns
0.30 ± 0.12 0.047 0.046 ns
0.25 ± 0.08 ns ns ns
2.73 ± 0.31 ns ns ns
5.08 ± 0.52 ns ns ns
2.92 ± 0.57 <0.001 0.016 <0.001
5.37 ± 0.84 0.010 ns 0.008
al Vein; ONr, Optical Nerve; MONr, maximum ONr diameter; PSV,
V, Maximum Velocity; MinV, Minimal Velocity; RI, Resistive Index;
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The data were analysed by SPSS 17.0. Demographic data
ere compared by independent samples t-test and chi
quare test, as appropriate. Data are reported as mean
ith standard deviation (SD) and as median and range inter-
uartile (RIQ), when appropriate. Comparisons of the other
ariables were performed with the analysis of variance
ANOVA) complemented with the pairwise comparison vs.
C according to Dunnett. Statistical signiﬁcance was set at
< 0.05.
esults
ll the results are shown in Table 2. For the OA and the
RA we found no difference for all variables. For the CRV
o detectable variation in velocities was found, while there
as a signiﬁcant difference in PI, that is greater in MS
atients’ eyes not affected by ONe vs. both HC and MS
atients’ eyes affected by ONe. ONr diameter measurement
t 3mm shows no difference between the three groups,
hile maximum ONr diameter is signiﬁcantly smaller in MS
atients’ both affected and unaffected eyes, compared to
C.
iscussion and conclusions
s far as the arterio-venous ophthalmic system is concerned,
ur data did not show any arterial abnormality or any major
enous ﬂow alteration (i.e. absence, blocked or reversed
ow). Recently, in MS patients with CCSVI, an association has
een reported between ONe and Internal Jugular Vein (IJV)
nd Azygous Vein stenoses, with reﬂux in the deep cerebral
eins. These ﬁndings suggest that the veins of the ONr might
e involved in a compensatory outﬂow circle towards the
JV.
In our sample of MS patients we did not observe any
lteration, in the ONr venous ﬂow that supports this hypoth-
sis. The increased CRV PI in MS patients’ unaffected eyes
s intriguing and seems not associated to ONr atrophy. This
ould suggest a venous drainage impairment, but at present
e cannot conﬁrm this hypothesis and larger studies are
eeded to conﬁrm it.
The analysis of the diameter of the ONrs showed that
t is possible to detect ONr atrophy in affected eyes and,
t a lesser degree, also in unaffected eyes of MS patients.
aximum ONr diameter measurement seems to be more
eliable than 3mm measurement, probably because of the
rogressive ONr myelination.
In conclusion, ultrasound examination of ONr and its
ascularisation is an easy, feasible, safe and low cost
rocedure and the measurement of ONr thickness can
etect ONr atrophy.
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ppendix A. Supplementary data
upplementary data associated with this article can be
ound, in the online version, at http://dx.doi.org/10.1016/
.permed.2012.04.008.
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